| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 84443 |
Thyroid stimulating hormone (TSH) |
556 |
444 |
$4K |
| 80053 |
Comprehensive metabolic panel |
598 |
488 |
$3K |
| 80061 |
Lipid panel |
766 |
616 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
585 |
475 |
$2K |
| 82607 |
|
446 |
372 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
559 |
467 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
651 |
537 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
17 |
13 |
$941.75 |
| 82746 |
|
200 |
161 |
$831.47 |
| 84439 |
|
381 |
311 |
$793.20 |
| 80074 |
|
32 |
26 |
$745.63 |
| 36415 |
Collection of venous blood by venipuncture |
1,048 |
817 |
$614.12 |
| 82728 |
|
38 |
37 |
$596.34 |
| 83735 |
|
179 |
122 |
$329.71 |
| 80050 |
General health panel |
217 |
207 |
$325.25 |
| 83550 |
|
32 |
30 |
$319.55 |
| 84436 |
|
173 |
145 |
$287.10 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$270.00 |
| 83540 |
|
34 |
31 |
$254.44 |
| 86708 |
|
33 |
26 |
$210.90 |
| 86704 |
|
32 |
25 |
$205.19 |
| 86706 |
|
34 |
27 |
$197.57 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
67 |
54 |
$155.44 |
| 84550 |
|
122 |
84 |
$138.91 |
| 84479 |
|
149 |
127 |
$121.12 |
| 81001 |
|
199 |
166 |
$99.70 |
| 85651 |
|
113 |
97 |
$70.19 |
| 86140 |
|
93 |
54 |
$65.59 |
| 83525 |
|
53 |
43 |
$15.68 |
| 99000 |
|
346 |
269 |
$0.00 |
| 82533 |
|
81 |
80 |
$0.00 |
| 83695 |
|
68 |
41 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
12 |
$0.00 |